PRTN3 and rheumatoid arthritis: Using ML for predicting RA with ACPA autoantibodies based on non-HLA gene polymorphisms would potentially enable to determine the group of individuals more prone to develop rheumatoid arthritis and further implement more precise preventive methods like smoking cessation.